Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
LDLR- |
RCV000237269 | SCV000295367 | pathogenic | Hypercholesterolemia, familial, 1 | 2016-03-25 | criteria provided, single submitter | literature only | |
Fundacion Hipercolesterolemia Familiar | RCV000237269 | SCV000607585 | pathogenic | Hypercholesterolemia, familial, 1 | 2016-03-01 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV001220026 | SCV001391997 | pathogenic | Familial hypercholesterolemia | 2022-05-14 | criteria provided, single submitter | clinical testing | This premature translational stop signal has been observed in individual(s) with familial hypercholesterolemia (PMID: 15241806). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 251788). This variant is also known as p.Y421X. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Tyr442*) in the LDLR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LDLR are known to be pathogenic (PMID: 20809525, 28645073). |
Ce |
RCV004567794 | SCV005051200 | pathogenic | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | LDLR: PVS1, PM2, PS4:Moderate |